marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-06-2024
Arcutis Biotherapeutics Income Statement 2011-2024 | ARQT
Annual Income Statement Arcutis Biotherapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
747 M | 882 M | 1.02 B | 1 B | - | - | - | - | - | - | - | - | - |
Shares |
69.3 M | 55 M | 49.4 M | 35.7 M | - | - | - | - | - | - | - | - | - |
Historical Prices |
10.8 | 16 | 20.7 | 28.1 | - | - | - | - | - | - | - | - | - |
Net Income |
-262 M | -311 M | -206 M | -136 M | -42 M | -19.3 M | -4.98 M | - | - | - | - | - | - |
Revenue |
59.6 M | 3.69 M | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
4.99 M | 754 K | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-241 M | -302 M | -207 M | -137 M | -43.1 M | -19.7 M | - | - | - | - | - | - | - |
Interest Expense |
29.7 M | 15.7 M | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-240 M | -301 M | -206 M | -137 M | -42.9 M | -19.7 M | -4.11 M | - | - | - | - | - | - |
Operating Expenses |
- | - | - | 137 M | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
185 M | 122 M | 61 M | 21.3 M | 6.61 M | 1.8 M | 695 K | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Arcutis Biotherapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
124 M | 123 M | 111 M | 96.8 M | 61.7 M | 61.4 M | 61.2 M | 61 M | 57.1 M | 51.4 M | 50.5 M | 50.3 M | 50.1 M | 50 M | 47.3 M | 43.3 M | 37.7 M | 37.6 M | 24.3 M | 2.12 M | 1.92 M | 1.77 M | 1.63 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-41.5 M | -52.3 M | -35.4 M | - | -44.8 M | -71 M | -80.1 M | - | -108 M | -67.4 M | -64.3 M | - | -57 M | -42 M | -36 M | -34 M | -38.2 M | -35.4 M | -28 M | -12.6 M | -14.5 M | -8.29 M | -6.66 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
44.8 M | 30.9 M | 49.6 M | - | 38.1 M | 5.19 M | 2.78 M | - | 725 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
5.5 M | 3.46 M | 3.26 M | - | 1.18 M | 776 K | 783 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-39.1 M | -50.1 M | -31.6 M | - | -36.9 M | -66.8 M | -76.3 M | - | -105 M | -65.8 M | -62.6 M | - | -57.1 M | -42.1 M | -36.1 M | - | -38.3 M | -35.6 M | -28.7 M | - | -14.6 M | -8.54 M | -6.95 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
4.18 M | 5.23 M | 7.48 M | - | 2.72 M | 3.12 M | 7.04 M | - | 4.9 M | 2 M | 1.84 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | -49.9 M | -31.5 M | - | -36.7 M | -66.6 M | -76.1 M | - | -105 M | -65.7 M | -62.5 M | - | -57 M | -42 M | -36 M | - | -38.3 M | -35.6 M | -28.6 M | - | -14.6 M | -8.51 M | -6.95 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | 75 M | 72 M | 79 M | - | 105 M | 65.8 M | 62.6 M | - | 57.1 M | 42.1 M | 36.1 M | 34.1 M | 38.3 M | 35.6 M | 28.7 M | 13 M | 14.6 M | 8.54 M | 6.95 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
58.8 M | 58.2 M | 54.8 M | - | 47.6 M | 46 M | 42.9 M | - | 35.5 M | 27.6 M | 22 M | - | 16.5 M | 11.3 M | 14.5 M | - | 5.56 M | 5.62 M | 3.47 M | - | 2.3 M | 1.32 M | 749 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency